Market revenue in 2023 | USD 622.8 million |
Market revenue in 2030 | USD 778.2 million |
Growth rate | 3.2% (CAGR from 2023 to 2030) |
Largest segment | Devices |
Fastest growing segment | Drugs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Devices, Drugs |
Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 90.93% in 2023. Horizon Databook has segmented the France hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
Extensively increasing prevalence of hearing impairment and associated diseases are likely to boost the industrial developments in France. Majority of the companies are focusing on development of new therapies and hearing aids with an aim to fulfill the gap of demand and supply.
In addition, market players are actively involving in international programs and campaigns to consolidate its position in the global market. For instance, in January 2023, France-based clinical stage biotechnology company, Sensorion, took part in the annual UNESCO Week of Sound.
The company is actively engaged in developing therapies for treatment of hearing impairment. Furthermore, in June 2020, CILcare announced strategic partnership with Vertidiag, a start-up actively operating in balance disorders. The strategic collaboration is planning to develop and introduce therapeutic solutions for hearing loss, tinnitus, and otitis.
Horizon Databook provides a detailed overview of country-level data and insights on the France hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into France hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account